Multimodal Hazard Rate for Relapse in Breast Cancer: Quality of Data and Calibration of Computer Simulation

Much has occurred since our 2010 report in Cancers. In the past few years we published several extensive reviews of our research so a brief review is all that will be provided here. We proposed in the earlier reports that most relapses in breast cancer occur within 5 years of surgery and seem to be...

Full description

Bibliographic Details
Main Authors: Michael Retsky, Romano Demicheli
Format: Article
Language:English
Published: MDPI AG 2014-11-01
Series:Cancers
Subjects:
Online Access:http://www.mdpi.com/2072-6694/6/4/2343
id doaj-1ff85bf3695e4e10842864dc6e57b80b
record_format Article
spelling doaj-1ff85bf3695e4e10842864dc6e57b80b2020-11-24T22:32:56ZengMDPI AGCancers2072-66942014-11-01642343235510.3390/cancers6042343cancers6042343Multimodal Hazard Rate for Relapse in Breast Cancer: Quality of Data and Calibration of Computer SimulationMichael Retsky0Romano Demicheli1Molecular and Integrative Physical Science, Harvard School of Public Health, Boston, MA 02115, USAScientific Directorate, Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, ItalyMuch has occurred since our 2010 report in Cancers. In the past few years we published several extensive reviews of our research so a brief review is all that will be provided here. We proposed in the earlier reports that most relapses in breast cancer occur within 5 years of surgery and seem to be associated with some unspecified manner of surgery-induced metastatic initiation. These events can be identified in relapse data and are correlated with clinical data. In the last few years an unexpected mechanism has become apparent. Retrospective analysis of relapse events by a Brussels anesthesiology group reported that a perioperative NSAID analgesic seems to reduce early relapses five-fold. We then proposed that primary surgery produces a transient period of systemic inflammation. This has now been identified by inflammatory markers in serum post mastectomy. That could explain the early relapses. It is possible that an inexpensive and non-toxic NSAID can reduce breast cancer relapses significantly. We want to take this opportunity to discuss database quality issues and our relapse hazard data in some detail. We also present a demonstration that the computer simulation can be calibrated with Adjuvant-on-line, an often used clinical tool for prognosis in breast cancer.http://www.mdpi.com/2072-6694/6/4/2343breast cancerbimodal and multimodal relapse patternsdatabase qualityearly relapsessurgeryperioperative NSAIDtransient systemic inflammation
collection DOAJ
language English
format Article
sources DOAJ
author Michael Retsky
Romano Demicheli
spellingShingle Michael Retsky
Romano Demicheli
Multimodal Hazard Rate for Relapse in Breast Cancer: Quality of Data and Calibration of Computer Simulation
Cancers
breast cancer
bimodal and multimodal relapse patterns
database quality
early relapses
surgery
perioperative NSAID
transient systemic inflammation
author_facet Michael Retsky
Romano Demicheli
author_sort Michael Retsky
title Multimodal Hazard Rate for Relapse in Breast Cancer: Quality of Data and Calibration of Computer Simulation
title_short Multimodal Hazard Rate for Relapse in Breast Cancer: Quality of Data and Calibration of Computer Simulation
title_full Multimodal Hazard Rate for Relapse in Breast Cancer: Quality of Data and Calibration of Computer Simulation
title_fullStr Multimodal Hazard Rate for Relapse in Breast Cancer: Quality of Data and Calibration of Computer Simulation
title_full_unstemmed Multimodal Hazard Rate for Relapse in Breast Cancer: Quality of Data and Calibration of Computer Simulation
title_sort multimodal hazard rate for relapse in breast cancer: quality of data and calibration of computer simulation
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2014-11-01
description Much has occurred since our 2010 report in Cancers. In the past few years we published several extensive reviews of our research so a brief review is all that will be provided here. We proposed in the earlier reports that most relapses in breast cancer occur within 5 years of surgery and seem to be associated with some unspecified manner of surgery-induced metastatic initiation. These events can be identified in relapse data and are correlated with clinical data. In the last few years an unexpected mechanism has become apparent. Retrospective analysis of relapse events by a Brussels anesthesiology group reported that a perioperative NSAID analgesic seems to reduce early relapses five-fold. We then proposed that primary surgery produces a transient period of systemic inflammation. This has now been identified by inflammatory markers in serum post mastectomy. That could explain the early relapses. It is possible that an inexpensive and non-toxic NSAID can reduce breast cancer relapses significantly. We want to take this opportunity to discuss database quality issues and our relapse hazard data in some detail. We also present a demonstration that the computer simulation can be calibrated with Adjuvant-on-line, an often used clinical tool for prognosis in breast cancer.
topic breast cancer
bimodal and multimodal relapse patterns
database quality
early relapses
surgery
perioperative NSAID
transient systemic inflammation
url http://www.mdpi.com/2072-6694/6/4/2343
work_keys_str_mv AT michaelretsky multimodalhazardrateforrelapseinbreastcancerqualityofdataandcalibrationofcomputersimulation
AT romanodemicheli multimodalhazardrateforrelapseinbreastcancerqualityofdataandcalibrationofcomputersimulation
_version_ 1725731572032733184